explore -WSS

explore

author：fashion 2025-08-25 16:35:07 - browse：94295

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Biotech incubator Curie.Bio graduates its first startup

WSS

How I ended up pumping milk in a bathroom stall at JPM 2024

Study: New antibiotic targets gonorrhea as well as last existing drug

Excited delirium, Elijah McClain, and emergency physicians

New menopause drug shows promise in relief for hot flashes

Excited delirium, Elijah McClain, and emergency physicians

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

leisure time

explore

hotspot

Peter Hotez and the public health issue of online harassment

DeSantis can now import cheaper drugs. But will Biden get credit?

Bright Health sells Medicare Advantage business to Molina

FDA approves Recor Medical high blood pressure device

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Alkermes shareholders re

Caregivers of transplant patients call for more support, training

Walensky prepares to leave CDC — and Congress — behind

Will General Catalyst be the first of many hospital takeovers?

focus

Biotech incubator Curie.Bio graduates its first startup

Victims of gun violence feel impacts long after bullet wound

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

As JPM 2024 winds down, some health tech firms project optimism

UCSF medical school apologizes for unethical prisoner experiments

Idaho abortion case may prompt more restrictions in other states

focus

hotspot

Wikipedia

explore